Zydus Cadila receives final approval from USFDA for Glycopyrrolate injection
Glycopyrrolate is used before surgery to decrease the volume of secretions from mouth, lungs and stomach
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Cadila
Centre places purchase order for one crore doses of Zydus Cadila’s needle-free COVID vaccine
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above
Zydus Cadila receives tentative approval from US FDA for Adapalene and Benzoyl Peroxide Gel
The product works by killing the bacteria that cause acne and by keeping the skin pores clean
Sustainability in Pharma– Leapfrogging into a Carbon Neutral World
Express Pharma, in association with SAP India, as part of the Life Sciences Industry Knowledge Exchange Forum, recently hosted a…
Zydus Cadila proposes Rs 1,900 for three-dose COVID vaccine; government negotiating to bring it down
The government is negotiating for a reduction in price and a final decision on it is likely to be taken this week
Government to introduce ZyCoV-D shortly
ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI) and will be administered to…
Zydus Cadila gets USFDA approval for Vortioxetine Tablets
Vortioxetine is used to treat depression. It works by helping to restore the balance of a certain natural substance (serotonin) in…
Zydus Cadila receives tentative approval from US FDA for Brexpiprazole tablets
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
Zydus Cadila’s Sitagliptin base tablets receive tentative approval from FDA
Zydus’ NDA received tentative approval upon completion of the first review cycle on 2nd September, 2021
Zydus Cadila gets US FDA approval for Tofacitinib extended-release 22 mg tablet
Zydus was the first ANDA filer on Tofacitinib extended-release tablets 22 mg and
currently holds 180-day exclusivity on this…